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We compared gene expression profiles of mouse and human ES cells by immunocytochemistry, RT-PCR, and membrane-based focused
cDNA array analysis. Several markers that in concert could distinguish undifferentiated ES cells from their differentiated progeny were
identified. These included known markers such as SSEA antigens, OCT3/4, SOX-2, REX-1 and TERT, as well as additional markers such as
UTF-1, TRF1, TRF2, connexin43, and connexin45, FGFR-4, ABCG-2, and Glut-1. A set of negative markers that confirm the absence of
differentiation was also developed. These include genes characteristic of trophoectoderm, markers of germ layers, and of more specialized
progenitor cells. While the expression of many of the markers was similar in mouse and human cells, significant differences were found in the
expression of vimentin, h-III tubulin, alpha-fetoprotein, eomesodermin, HEB, ARNT, and FoxD3 as well as in the expression of the LIF
receptor complex LIFR/IL6ST (gp130). Profound differences in cell cycle regulation, control of apoptosis, and cytokine expression were
uncovered using focused microarrays. The profile of gene expression observed in H1 cells was similar to that of two other human ES cell
lines tested (line I-6 and clonal line-H9.2) and to feeder-free subclones of H1, H7, and H9, indicating that the observed differences between
human and mouse ES cells were species-specific rather than arising from differences in culture conditions.
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Introduction Much has been learned from the generation of mouse ESEmbryonic stem cell (ES cell) lines were first generated
from mouse blastocysts by culturing inner cell mass (ICM)
from pre-implantation embryos on feeder layers (Evans
and Kaufman, 1981; Martin, 1981). The resulting cultures
contained populations of cells, which grew as colonies,
showed extensive capacity for replication, and were plu-
ripotent as demonstrated by their ability to generate chi-
meras and transgenic mice and to differentiate in culture
into ectodermal, endodermal, and mesodermal derivatives.0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.12.034
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E-mail address: raomah@grc.nia.nih.gov (M.S. Rao).cell lines in terms of methods of propagation, growth
factor dependence, and marker expression. Mouse ES cells
express genes characteristic of the early blastocyst such as
the POU domain transcription factor OCT3/4 (Rosner et
al., 1990; Scholer et al., 1990), the homeobox domain
transcription factor SOX-2 (Yuan et al., 1995), the zinc
finger protein REX-1 (Rogers et al., 1991), the transcrip-
tional activator UTF-1 (Okuda et al., 1998), as well as
carbohydrate epitopes SSEA-1, and SSEA-3 identified
using specific antibodies at the preimplantation embryo
stage (Krupnick et al., 1994). Mouse ES cells do not
differentiate into trophoectoderm (Edwards, 2002), they
can be propagated in continuous culture on a feeder layer
of mouse embryonic fibroblasts or without feeders in the
presence of leukemia inhibitory factor (LIF) (Smith and
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LIF-related cytokines (Conover et al., 1993; Pennica et al.,
1995; Rose et al., 1994; Wolf et al., 1994), retain high
telomerase levels, show karyotypic stability, and retain the
ability to contribute to chimeras and form teratomas
(reviewed in Burdon et al., 2002; Edwards, 2002; Gardner,
2002; Prelle et al., 2002; Rossant, 2001) after multiple
passages in culture.
More recently, primate and human ES cell lines have
been isolated. The first success was reported by Thomson
et al. who isolated several monkey (Thomson and Mar-
shall, 1998; Thomson et al., 1998b) and subsequently five
human ES cell lines (Thomson et al., 1998a). This result
has been replicated by several laboratories (reviewed in
Carpenter et al., 2003), and sixty-four different derivations
are now listed in the NIH registry for research use (http://
escr.nih.gov). Currently, fewer than 10 cell lines are avail-
able in sufficient numbers for analysis, and only limited
data on the fundamental properties of these lines are
available. Recent studies, while limited, suggest that differ-
ences exist between mouse and human ES cell lines.
Similar to mouse ES cells, which express mouse-specific
embryonic antigens such as SSEA-1, at least some of the
human ES cell lines express surface markers (glycolipids
and glycoproteins) that were originally identified on human
embryonic carcinoma cells (EC cells), such as SSEA-3,
SSEA-4, TRA-1-81, TRA-1-60 (Draper et al., 2002; Hen-
derson et al., 2002). On the other hand, human ES cells,
unlike their mouse counterparts, do not appear to require
LIF for their propagation or for maintenance of pluripo-
tency (Reubinoff et al., 2000; Thomson et al., 1998a).
Whether LIF has different effects or its action is actively
inhibited in human ES cells as has been proposed in EC
cells (Schuringa et al., 2002) remains to be determined.
Furthermore, in contrast to mouse ES cells (Niwa et al.,
2000; Rossant, 2001), human ES cells are able to differ-
entiate into trophoblast-like cells (Odorico et al., 2001;
Thomson et al., 1998a). Telomerase biology is different
between mouse and humans (Forsyth et al., 2002) and
differences in telomerase regulation in ES cells are likely,
though no reliable comparisons exist. These differences
suggest that caution must be exercised in extrapolation of
the data that has accumulated on the properties of mouse
ES cells to studies using human ES cells, and further
studies analyzing the similarities and differences between
mouse and human lines are required.
In this manuscript, we have compared a commonly
used mouse ES cell line (D3) with the most easily
available human ES cell line (H1) to assess similarities
and differences when the cells are grown under similar
conditions by the same laboratory. We show that several
of the markers used to assess mouse ES cells can be used
to examine human ES cells as well. Differences exist,
however, in morphology, patterns of embryonic antigen
immunostaining, expression of differentiation markers, as
well as expression profiles of cytokines, cell cycle, andcell death-regulating genes. These differences were con-
sistent across three different human ES cell lines tested
and suggest that fundamental species-specific differences
exist.Methods
Cell culture
Human ES cell line H1 was obtained from WiCell Re-
search Institute, Inc., (Madison, WI) and cultured according
to their instructions. Briefly, cells were cultured on mouse
embryonic fibroblast (MEF) feeders in ES cell medium
consisting of DMEM/F12 (Invitrogen/GIBCO 11330-032)
supplemented with 20% knockout serum replacement, 100
mMMEM nonessential amino acids, 0.55 mM beta-mercap-
toethanol, 2 mM L-glutamine, antibiotics/antimycotics, and
with 4 ng/ml human basic fibroblast growth factor (bFGF)
(all from Invitrogen/GIBCO). MEF’s derived from E12.5
mouse embryo were purchased from StemCell Technologies,
Inc. (Vancouver, Canada). MEF were expanded on 0.5%
bovine gelatin-coated dishes in DMEMmedium (Invitrogen/
GIBCO, cat# 11965-092) supplemented with 10% FBS (heat
inactivated, Hyclone cat# 3007103), 2 mM glutamine and
100 mM MEM nonessential amino acids. Subconfluent
MEF’s cultures were treated with 10 Ag/ml Mitomycin C
(Sigma, St. Louis, MO) for 3 h to arrest cell division, trypsi-
nized, and plated at 2 104/cm2 onto 0.5% bovine gelatin-
coated dishes overnight. Feeders were washed twice with
PBS, and then incubated in ES cell medium for at least 1
h before plating ES cells. MEF’s of passages 2–3 were used
as feeders. ES cells plated on top of MEF feeders were
cultured at 37jC in the atmosphere of 5% CO2/5% O2 within
a humidified tissue culture incubator from Thermo Forma.
H9.2 and I-6 cells were cultured at 21% O2. When confluent
(8–10 days after plating), ES cells were treated with 1 mg/ml
collagenase, type IV (Invitrogen/GIBCO) for 5–10 min and
gently scrapped off with 5-ml pipette. Cells were spun at 500
rpm for 3 min and the pellet was replated at 1:2–3 split or
used for RNA purification.
Mouse ES cell line D3 was obtained from ATCC and were
first expanded on fibroblast feeders treated with 10 Ag/ml
Mitomycin C as described above. In some experiments, STO-
1 feeder cells (also from ATCC) were used. Subconfluent D3
cultures were trypsinized and replated (1:3 split) onto 0.5%
bovine gelatin-coated tissue culture plates in the presence of
1,400 U/ml of leukemia inhibitory factor (LIF) (Chemicon,
ESG1106) in mouse ES cell medium consisting of knockout
Dulbecco’s minimal essential medium (DMEM) (Invitrogen/
GIBCO 10829-018) supplemented with 15% ES-qualified
FBS (Invitrogen/Gibco 16141-061), 100 mM MEM nones-
sential amino acids, 0.55 mM beta-mercaptoethanol, 2 mM L-
glutamine, and antibiotics (all from Invitrogen/GIBCO).
When confluent (2–3 days after plating), D3 cells were
harvested by trypsinization and replated for immunostaining
Table 1
Primers used for RT-PCR
GENE UniGene PRIMERS References UniGene PRIMERS References
ABCG-2 Mm.196728 F: CCATAGCCACAGGCCAAAGT This laboratory Hs.194720 F: GTTTATCCGTGGTGTGTCTGG (Zhou et al., 2001)
R: GGGCCACATGATTCTTCCAC R: CTGAGCTATAGAGGCCTGGG
Cx 43 Mm.4504 F: TACCACGCCACCACTGGCCCA This laboratory Hs.74471 F: TACCATGCGACCAGTGGTGCGCT (Chang et al., 1999)
R: ATTCTGGTTGTCGTCGGGGAAATC R: GAATTCTGGTTATCATCGGGGAA
Cx 45 Mm.3096 F: GGGCAAACCAATTCCACCACC This laboratory Hs.283746 F:CTATGCAATGCGCTGGAAACAACA (Chang et al., 1999)
R: CAAGATTAAATCCAGACGGAG R: CCCTGATTTGCTACTGGCAGT
FGFR-4 Mm.4912 F: TCCGACAAGGATTTGGCAG This laboratory Hs.165950 F: GTTTCCCCTATGTGCAAGTCC (Tartaglia et al., 2001)
R: GCACTTCCGAGACTCCAGATAC R: GCGCTGCTGCGGTCCATGT
FOXD3 Mm.4758 F: TCTTACATCGCGCTCATCAC (Hanna et al., 2002) Hs.120204 F: CGACGACGGGCTGGAGGAGAA This laboratory
R: TCTTGACGAAGCAGTCGTTG R: ATGAGCGCGATGTACGAGTA
Glut-1 Rn.30044 F: CAGTCAGCAATGAAGTCCAG This laboratory Hs.169902 F: GTGTTCGGCCTGGACTCCAT (Baroni et al., 1998)
R: AGCAGTAAGTTCTCAGCCTC R: AGTGGGAAGAAGGCCAGGGCT
OCT3/4 Mm.17031 F: GGAGAGGTGAAACCGTCCCTAGG (Anderson et al., 1999) Hs.2860 F: CTTGCTGCAGAAGTGGGTGGAGGAA This laboratory
R: AGAGGAGGTTCCCTCTGAGTTGC R: CTGCAGTGTGGGTTTCGGGCA
REX-1 Mm.3396 F: GGCCAGTCCAGAATACCAGA (Thompson and Hs.169832 F: TGAAAGCCCACATCCTAACG This laboratory
R: GAACTCGCTTCCAGAACCTG Gudas, 2002) R CAAGCTATCCTCCTGCTTTGG
SOX2 Mm.4541 F: GTGGAAACTTTTGTCCGAGAC This laboratory Hs.816 F: ATGCACCGCTACGACGTGA This laboratory
R: TGGAGTGGGAGGAAGAGGTAAC R CTTTTGCACCCCTCCCATTT
TERF1 Mm.4306 F: TTCAACAACCGAACAAGTGTC (Klapper et al., 2001) Hs.194562 F: GCAACAGCGCAGAGGCTATTATT (Yajima et al., 2001)
R: TCTCTTTCTCTTCCCCCTCC R: AGGGCTGATTCCAAGGGTGTAA
TERF2 Mm.6402 F: GCCCAAAGCATCCAAAGAC (Klapper et al., 2001) Hs.100030 F: AAACGAAAGTTCAGCCCCG (Yajima et al., 2001)
R: ACTCCATCCTTCACCCACTC R: TCCTCCAAGACCAATCTGCTTA
TERT Mm.10109 F: CTGCGTGTGCGTGCTCTGGAC (Klapper et al., 2001) Hs.115256 F: AGCTATGCCCGGACCTCCAT This laboratory
R: CACCTCAGCAAACAGCTTGTTCTC R: GCCTGCAGCAGGAGGATCTT
AFP Mm.80 F: GTTTTCTGAGGGATGAAACCTATG (Cantz et al., 2003) Hs.155421 F: AAATACATCCAGGAGAGCCA (Lafuste et al., 2002)
R: GAAGCTCTTGTTTCATGGTCTGTA R: CTGAGCTTGGCACAGATCCT
Actc1 Mm.195067 F: ACAATGTCCTATCTGGAG This laboratory Hs.119000 F: CACTGAATCCGCCTACCTCC (Karkkainen et al., 2002)
R: GTACAATGACTGATGAGAGA R: TCGTGCCTCTACACCAGACC
Brachyury Mm.913 F: GCTGTGACTGCCTACCAGCAGAATG This laboratory Hs.143507 F: TAAGGTGGATCTTCAGGTAGC (Gokhale et al., 2000)
R: GAGAGAGAGCGAGCCTCCAAAC R: CATCTCATTGGTGAGCTCCCT
brain1 Rn.11354 F: CACAGCCCGCCCTCCT This laboratory Hs.210862 F: TGGACTCAACAGCCACGAC This laboratory
R: CAGAACCAGACCCGCACGAC R: TGAACGCTCGTCTGCAGC
HNF3-b Mm.938 F: GGACGTAAAGGAAGGGACTCCAC (Maeyama et al., 2001) Hs.155651 F: GACAAGTGAGAGAGCAAGTG This laboratory
R: GCAGCCCATTTGAATAATCAGCTCAC R: ACAGTAGTGGAAACCGGAG
Krt1-14 Mm.6974 F: ATTCTCCTCATCCTCTCAAT This laboratory Hs.455013 F: AGCTCCATGAAGGGCTCCTG (Werner and Munz, 2000)
R: GACAAGGGTCAAGTAAAGAG R: CATGGTCACCTTCTCACTGC
Krt1-15 Mm.38498 F: CACCACATTCTTGCAAAC This laboratory Hs.418220 F: GGAGGTGGAAGCCGAAGTAT (Werner and Munz, 2000)
R: ATTAAGGTTCTGCATGGTC R: GAGAGGAGACCACCATCGCC
Msx1 Mm.259122 F: GCTATGACTTCTTTGCCACTCG (Wang and Sassoon, 1995) Hs.424414 F: CCTTCCCTTTAACCCTCACAC This laboratory
R: TTAAGAGAAGGGGACCAGGTGG R: CCGATTTCTCTGCGCTTTTC
Myf5 Mm.4984 F: TGCCATCCGCTACATTGAGAG (Kruger et al., 2001) Hs.178023 F: GCCCGAATGTAACAGTCCTGTC This laboratory
R: CCGGGGTAGCAGGCTGTGAGTTG R: TAAGCCTGGAACTAGAAGCCCC
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Nestin Mm.23742 F: AGTGTGAAGGCAAAGATAGC This laboratory X65964 F: CAGCGTTGGAACAGAGGTTGG (Ignatova et al., 2002)
R: TCTGTCAGGATTGGGATGGG R:TGGCACAGGTGTCTCAAGGGTAG
beta 3 tubulin Mm.40068 F: TCACTGTGCCTGAACTTACC This laboratory Hs.159154 F: CAACAGCACGG CATCCAGG (Ranganathan et al., 1996)
R: GGAACATAGCCGTAAACTGC R: CTTGGGGCCCTG GCCTCCGA
vimentin Mm.7 F: AAGGGTGAGTAGAGAGTTC This laboratory Hs.297753 F:GACACTATTGGC CCTGCGGATGAG (Nishio et al., 2001)
R: AACACTGTTAGGAAAGAGG R: CTGCAGAAAGG ACTTGAAAGC
Pdx1 Mm.4949 F: CGGACATCTCCCCATACG (Laybutt et al., 2002) Hs.32938 F: GTCCTGGAGGA CCAAC (Itkin-Ansari et al., 2000)
R: AAAGGGAGCTGGACGCGG R: GCAGTCCTGCTC GGCTC
ARNT Mm.4316 F: ACTTTGTCAAGCTCATTTCC (Naruse et al., 2002) Hs.166172 F: GCTGCTGCCTAC CTAGTCTCA (Lin et al., 2003)
R: TGCAGCGAACTTTATTGATG R: GCTGCTCGTGTC GGAATTGT
Bex1/Rex3 Mm.14768 F: CCAGGGAAGGATGAGAGA (Brown and Kay, 1999) Hs.334370 F: ACAGGCAAGGA AGAGAAG This laboratory
R: TAGAAGCTGGTAACAGGGAG R: CCCACGTAAAC GTGACAG
eomesodermin Mm.200692 F: GAGCCCTCAAAGACCCAGA (Kimura et al., 1999) Hs.301704 F: AATATCGGTGTT GGTAGG (Kimura et al., 1999)
R: CTAGGGACTTGTGTAAAAAGC R: GTCCTCAGGGG GGAGC
Hand1 Mm.4746 F: GGATGCACAAGCAGGTGAC (Thattaliyath et al., 2002) Hs.152531 F: TGCCTGAGAAA GAACCAG (Knofler et al., 2002)
R: CACTGGTTTAGCTCCAGCG R: ATGGCAGGATG CAAACAC
HEB Mm.36894 F: CCATCCCCAAATTCTGACGAT (Ortman et al., 2002) Hs.21704 F: ACTGAAAACAA GAAAAGGATGAAAACC (Knofler et al., 2002)
R: GCTGGCTCATCCCATTCG R:CCCTTTCTATCTT TGTTCAGGGTTC
mash2 Mm.196417 F: CAATAAAGATGACCTCTGTCCC This laboratory Hs.1619 F: CTCGCCCTCCCG GGTTCTT (Westerman et al., 2001)
R: GAATAGTACACTTTGCAACAGC R: CCAGCAGTGTC TCCAGCAG
gp130 Mm.4364 F: CAGCACCAAGGATTTGGCTAGC (Spence et al., 2001) Hs.82065 F: GGTACGAATGGC GCATACA (Sherwin et al., 2002)
R: GAAGTGCCATGCTTTGACTGGC R: CTGGACTGGATT ATGCTGA
LIFR Mm.3174 F: CGGAATTCCTGACATATCCCAGAAGACACT (Ni et al., 2002) Hs2758 F: CTGGAACAGGC TGGTAC (Knight et al., 1999)
R: GCTCTAGAGCATCTGTGGCTTATAGCCT R: ACTCCACTCTTC AGACCAG
ubiquitin C Mm.331 F: AAGACCATCACCTTGGACG This laboratory Hs.183704 F: CCCAGTGACAC TCGAGAATG This laboratory
R: CCAAGAACAAGCACAAGGAG R: AACTTAGACAC CCCCTCAAG
p16ink4a Mm.4733 F: CATAGCTTCAGCTCAAGCAC This laboratory Hs.1174 F: CACCGCTTCTGC TTTTCAC This laboratory
R: CAATCCAGCCATTATTCCCTTC R: AGCTTTGGTTCT CCATTTGC
cyclin D2 Mm.3141 F: AGCTTCCAAGCTGAAAGAGACC This laboratory Hs.75586 F: TGTGAGGAACA AGTGCGAAG This laboratory
R: CAACACTACCAGTTCCCACTCC R: AACATGCAGAC GCACCCAG
mdm2 Mm.22670 F: GAATCCTCCCCTTCCATCACAC This laboratory Hs.170027 F: AGCAGGAATCAT GGACTCAGG This laboratory
R: AAGCCTTCTTCTGCCTGAGC R: CACACAGAGCC GGCTTTCATC
GADD45 Mm.1236 F: GTTACTCAAGCAGTCACTCCCC This laboratory Hs.80409 F: TTGTTTTTGCCG GAAAGTCG This laboratory
R: TCTTCAGGCTCACCTCTCTCTC R: TTGAACTCACTC GCCCCTTG
TNFR2 Mm.1258 F: GAACAATTCCATCTGCTGCACC This laboratory Hs.256278 F: TGGACTGATTGT GGTGTGAC This laboratory
R: TTACAGCCACACACCGTGTC R: TTATCGGCAGGC AGTGAGG
TRAF1 Mm.12898 F: TGCAGAGCAGACAACCTCCATC This laboratory Hs.2134 F: TGTACCTGAATG AGATGGCAC This laboratory
R: TCCCCTTGAAGGAACAGCCAAC R: TCTGGTCCAGCA CATGAAG
CSF1 Mm.795 F: ACATCCACCACTACCCTCTC This laboratory Hs.173894 F: CCCTCCTCCAAA TTCAACTCC This laboratory
R: ACCCCATCAAAGCTGCTTC R: ATCCTCTGACCT CCCTGAATC
FGF11 Mm.269011 F: ATCCCGATGGGAGTATCCAG This laboratory Hs.31339 F: GCTCCTTCACCC CTTCAAC This laboratory
R: GCAGAGGCATACAGGACATAG R: GGCGTACAGGA GTAGTAATTC
IL19 Mm.131480 F: CGCCTCATAGAAAAGAGTTTCC This laboratory Hs.71979 F: CAAGAAATCAA GAGCCATCC This laboratory
R: GCAATGCTGCTGATTCTCC R: CTCTGTTCCTGA ATTGCC
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Table 2
Antibodies used for immunofluorescence
Epitope name Clone Dilution Description Source
A2B5 A2B5 1:20 Mouse IgM ATCC
BCRP1 5D3 1:200 Mouse IgG2b Chemicon
CD44 Hermes-3 1:25 Mouse IgG Sherman et al.,
2000
GFAP – 1:500 Rabbit DAKO
ENCAM 5A5 1:5 Mouse IgM DSHB
Nestin
(anti-human)
Nestin 331B 1:2000 Rabbit Messam et al.,
2000
Nestin Rat401 1:5 Mouse IgG1 DSHB
h-III tubulin SDL.3D10 1:2000 Mouse IgG2b Sigma
h-III tubulin the same
as TUJ-1
1:2000 Rabbit Covance
CD15S; anti-
sialyl LeX
CSLEX1 1:200 Mouse IgM BD
Connexin43 – 1:1000 Rabbit Chemicon
FGFR-4 137105 1:20 Mouse IgG R & D
Systems
FGFR-4 VBS1 1:250 Mouse IgM Chemicon
HNF3-beta 4C7 1:50 Mouse IgG1 DSHB
Islet1 394D5 1:50 Mouse IgG2b DSHB
Notch-1 BTAN20 1:50 Rat IgG DSHB
OCT3/4 N-19 1:100 Goat Santa Cruz
Sox-2 – 1:2000 Rabbit Dr. L. Pevny,
(Kamachi et al.,
1995)
Sox-2 – 1:2000 Rabbit Chemicon
SOX-2 – 1:200 Rabbit Abcam
SSEA-1 MC-480 1:50 Mouse IgM DSHB
SSEA-3 MC-631 1:50 Rat IgM DSHB
SSEA-4 MC-813-70 1:50 Mouse IgG3 DSHB
TRA-1-60 TRA-1-60 1:100 Mouse IgM Chemicon
TRA-1-81 TRA-1-81 1:100 Mouse IgM Chemicon
TRA-2-10 TRA-2-10 1:50 Mouse IgG1 DSHB
Vimentin V9 1:50 Mouse IgG1 Sigma
I. Ginis et al. / Developmental Biology 269 (2004) 360–380364onto glass coverslips coated with gelatin or used for RNA
purification.
Gene detection by RT-PCR
Total RNAwas isolated from cell pellets using RNAeasy
Qiagen mini protocol. cDNA was synthesized using 100 ng
to 1 Ag of total RNA in a 20-Al reaction. Superscript II
(Invitrogen), a modified Maloney murine leukemia virus
RT, and Oligo (dT) 12–18 primers were used according to the
manufacturer’s instructions. Aliquots of cDNA, equivalent
to 1/20 of the above reaction, were used in a 20-Al reaction
volume. PCR amplification of different genes was per-
formed using RedTaq DNA polymerase (Sigma). PCR
reactions were run for 35 cycles (94 jC for 30 s, 55 jC
for 30 s, and 72 jC for 1 min) and incubated at 72jC for 10
min at the end to ensure complete extension. The PCR
products were subjected to electrophoresis in 1.5% agarose
gel containing 0.5 Ag/ml ethidium bromide. One hundred-
basepair DNA ladder (Invitrogen; catalog # 10380-012) was
used to estimate size of the amplified bands. Table 1 lists the
primers used for RT-PCR.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for 20 min at
room temperature. Fixed cells were blocked for 1 h at room
temperature with PBS/0.1% BSA/10% normal goat serum/
0.3% Triton X-100 and then incubated overnight with
primary antibodies in PBS/0.1% BSA/10% normal goat
serum at 4jC. The list of primary antibodies and their
working dilutions are shown in Table 2. After three washes
in PBS/0.1% BSA, fluorescent secondary antibodies (Mo-
lecular Probes and Jackson ImmunoResearch) at 1:200
dilution in PBS were incubated with cells for 1 h at room
temperature to detect expression. Double labeling experi-
ments were performed by simultaneously incubating cells in
appropriate combinations of primary antibodies, followed
by incubation with noncross-reactive secondary antibodies.
Staining with antibodies against the cell surface markers E-
NCAM, A2B5 was carried out in cultures of living cells
without blocking in culture medium for 1 h at 37jC.
Staining for alkaline phosphatase was performed with a
kit (Sigma 85L1-1-KT) according to the manufacturer’s
protocol.
Electron microscopy
Undifferentiated H1 and D3 were grown on a MEF
feeders. Once they formed sizable colonies, they were fixed
with 5% glutaraldehyde for 3 h and processed for electron
microscopy. They were postfixed in osmium tetroxide,
embedded in plastic, semi-thin sectioned at 1 Am, and
stained with toluidine blue. In addition, thin sections were
prepared for electron microscopy according to standard
protocols (Wood et al., 1990).cDNA microarrays
The nonradioactive GEArrayk Q series cDNA expres-
sion array filters for human and mouse cell cycle, apoptosis
and cytokine genes (Cat #: HS-001N, HS-002N, HS-003N
and MM-001N, MM-002N, MM-003N, respectively, Super-
Array Inc.) were used according to the manufacturer’s
protocol. Total RNA was isolated from cell pellets using
RNAeasy Qiagen mini protocol and kit. The biotin dUTP
labeled cDNA probes were specifically generated in the
presence of a designed set of gene-specific primers using
total RNA (4 mg per filter) and 200 U MMLV reverse
transcriptase (Promega). The array filters were hybridized
with biotin-labeled probes at 60jC for 17 h. After that, the
filters were first washed twice with 2  SSC/1% SDS and
then twice with 0.1  SSC/1% SDS at 60 jC for 15 min
each. Chemiluminescent detection was performed by sub-
sequent incubation of the filters with alkaline phosphatase-
conjugated streptavidin and CDP-Star substrate. Array
membranes were exposed to X-ray film. Quantification of
the gene expression was performed with ScionImage soft-
ware. Mode OD of each gene/spot was calculated and
normalized to expression of GAPDH. Human and mouse
I. Ginis et al. / Developmental Biology 269 (2004) 360–380 365genes and OD values were aligned. Some human genes had
no counterparts on mouse arrays and vice versa. cDNA
microarray experiments were done twice with new filters
and RNA isolated at different times.
Telomerase activity
Telomerase was measured using the telomeric repeat
amplification protocol (TRAP) assay as described (Kim et
al., 1994; Weinrich et al., 1997), Terminal restriction frag-
ment (TRF) size was determined using Southern hybridiza-
tion as described (Allsopp et al., 1992; Harley et al., 1990).
EST-enumeration
EST frequency counts of genes expressed in human ES
cells were performed as described (Brandenberger et al.,
submitted for publication). Briefly, cDNA libraries of
human ES cell lines H1, H7, and H9 grown in feeder-
free conditions, embryoid bodies (EB), and two differen-
tiated subpopulations were constructed and submitted for
EST sequencing. The EST sequences were assembled into
overlapping sequence assemblies and mapped to the
UniGene database of nonredundant human transcripts.
Expression levels were assessed by counting the number
of ESTs for a particular gene that were derived from the
undifferentiated human ES cells and comparing them toFig. 1. Electron microscopy of undifferentiated mouse ES and human ES cells
magnification. Small arrows point to autophagosomes and the large arrow points
(original magnification 20,000). (C) Tight junctions (arrow) and gap junctions
magnification view of the autophagosome (original magnification 10,000). (E–G
G) Tight junctions (arrow) and gap junctions (arrowheads) can be seen (originalthe number of ESTs derived from the differentiated sub-
populations. Statistical significance was determined using
the Fisher Exact Test (Siegel and Castellan, 1988). Ex-
pression levels are presented as number of EST expressed
in the undifferentiated human ES cells, and embryoid
bodies (EB), for example, for Oct-4 [ES:EB], the numbers
are [24:1] indicating that there are 24 ESTs encoding Oct-
4 found in the undifferentiated human ES cells and 1 EST
in EBs.Results
Assessment of human and mouse ES cell cultures based on
morphology and on expression of commonly used markers
Undifferentiated mouse and human ES cell were cultured
and assessed by electron microscopy, immunocytochemistry
and RT-PCR. Many similarities and numerous differences
between the undifferentiated human H1 and mouse D3 cells
were noted. On electron microscopy examination (Fig. 1).
H1 cells formed a 2- to 4-cell layer over the feeder cells. In
contrast, D3 cells (Fig. 1) formed aggregates with 4–10 cell
layer thickness over the feeder layer. Phase contrast photo-
graphs (see Fig. 2A panels a and b) demonstrated that
human ES cells unlike mouse ES cells formed round
colonies with well-defined edges, a pattern similar to find-: (A–D) Mouse D3 cells. (A) Composite of nine fields taken at 2,000
to an apoptotic body. (B) Cells at the colony edge often had microvillae
(arrowheads) can be seen (original magnification 17,000). (D) A higher
) Human H1 cells. (E) A low power (2000) electron micrograph. (F and
magnification 20,000 and 30,000 for F and G, respectively).
Fig. 2. Characterization of undifferentiated state of H1 human and D3 mouse ES cells with commonly used markers. (A) Immunostaining. Panels a and b are
phase contrast microphotographs of live H1 and D3 cultures. Unlike D3 cells, H1 cells form round colonies with well-defined edges. (c,d) SSEA-1 staining;
(e,f) SSEA-4; (B) RT-PCR results. Genes previously reported to be associated with pluripotent state (OCT3/4, SOX-2; REX-1 and TERT) are expressed in both
types of cells. All experiments performed at least twice. (C) expression of TRA-1-60 (g) and TRA-1-81 (h) SOX-2 (i) and OCT3/4 (j) in H1 cells. Scale bars =
200 Am.
I. Ginis et al. / Developmental Biology 269 (2004) 360–380366ings by other labs. Both the H1 and D3 cells had a large
nucleus-to-cytoplasm ratio with numerous ribosomes. Both
ES cell colonies had a clearly polarized structure with the
ES cells harboring numerous villae facing the feeding
medium. There were tight junctions and gap junctions
among cells in both ES cell lines, especially close to the
surface (Figs. 1C, D, F, and G for mouse and human cells,
respectively). These findings were consistent with our
immunostaining for Connexin 43 (see Fig. 3). No highly
organized intermediate filamentous structures, such as neu-
rofilaments, that are suggestive of differentiation were seen.
Small aggregates of microtubular bundles ran in the perim-
eter of the nuclei. One finding that clearly segregated D3
cells from H1 cells was the presence of many apoptotic
cells, especially close to the edge of the colony, and
autophagosomes in almost a quarter of all of the mouse
ES cells. These electron dense lysosomal structures were
rare in human ES cells.
The quality of D3 and H1 cells cultured in our laboratory
was confirmed by evaluating the expression of several
markers that are expressed by undifferentiated ES cells
(Carpenter et al., 2001; Reubinoff et al., 2000; Thomson et
al., 1998a). Mouse D3 cells expressed SSEA-1 but did notexpress SSEA-4, while H1 cells exhibited reciprocal expres-
sion of these stage-specific embryonic antigens (Fig. 2). Both
cell lines expressed SSEA-3, although SSEA-3-positive cells
were less abundant in mouse cultures (data not shown). In
addition, H1 cells (but not D3 cells) expressed TRA-1-60 and
TRA-1-81 antigens (data for D3 cells not shown).
RT-PCR was performed to assess expression of genes
characteristic for ES cells such as OCT3/4 (Okamoto et al.,
1990; Rosner et al., 1990), SOX-2 (Avilion et al., 2003;
Cai et al., 2002), BEX/REX-1 (Ben-Shushan et al., 1998;
Rosfjord and Rizzino, 1994), and TERT (Armstrong et al.,
2000; Niida et al., 1998). Bands of the appropriate size
were observed for all these genes using species-specific
primers (Fig. 2), confirming that the cells grown in our
laboratory appeared similar to previously described undif-
ferentiated ES cells. OCT3/4 and SOX-2 protein expres-
sion was confirmed with immunostaining. Most D3 and
H1 cells were positive for SOX-2 and Oct 3/4 (Fig. 2 and
data not shown). Overall, these results demonstrate that D3
and H1 cells were not different significantly in morphol-
ogy, antigen immunostaining, and pluripotency marker
expression when compared to reports from other laborato-
ries but differed from each other.
Fig. 3. Characterization of undifferentiated state of H1 human and D3 mouse ES cells with an expanded set markers. (A) Results of immunostaining. Panels a,
c, e, f, h, j, mouse cells; panels b, d, g, i, k, human cells. (a,b) FGFR-4; (c,d) connexin-43 (all insets-membrane localization); (e) BCRP1 mouse cells; (f) double
staining for vimentin and undifferentiated state marker SSEA-1 (g) human cells; double staining for vimentin and undifferentiated state marker TRA-1-81. (h,i)
beta-tubulin class III in mouse and human cells, respectively, (j,k) double staining for beta-tubulin class III and for SSEA-1 and SSEA-4 in mouse and human
cells, respectively. All photographs are taken under 20 magnification; scale bars = 200 Am; ND: not detected. (B) RT-PCR analysis of additional markers of
undifferentiated state. (C) RT-PCR analysis of trophoectoderm markers. ST-standard 100 kb DNA ladder. (D) RT-PCR analysis of germ layer markers. Only
positive results are presented. (E) Comparison of telomerase activity. Different amounts (0, 50, 200 ng) of cell extracts from HeLa (positive control), D3 and H1
cell lines were assayed for telomerase activity by TRAP assay. HI-heat-inactivated extract (1000 ng) was used as a negative control.
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Table 3
Gene expression in human H1 and mouse D3 ES cells was analyzed using
RT-PCR and immunostaining. Representative (mainly positive) results of
these experiments are presented in Figs. 1 and 2. Antibodies and primer
sequences are listed in Tables 1 and 2, respectively. (A) markers of
undifferentiated state; (B) trophoectoderm markers; (C) markers of
germlayer differentiation. Black boxes—commonly expressed markers;
white boxes—markers are not expressed in both H1 and D3 cells; gray
boxes—markers are differently expressed in H1 and D3 cells.
tal Biology 269 (2004) 360–380Additional markers that serve to characterize mouse and
human ES cell lines
To expand the list of markers expressed in undifferenti-
ated cells, we tested expression of additional markers of
pluripotency that are thought to be controlled by OCT3/4
and SOX-2 genes, such as UTF-1 (Nishimoto et al., 1999;
Okuda et al., 1998), FOXD3 (Hanna et al., 2002) and
FGFR-4 (McDonald and Heath, 1994; Niswander and
Martin, 1992; Wilder et al., 1997) and telomerase-associated
factors TERF1 and TERF2 (Broccoli et al., 1997; Karlseder
et al., 1999; van Steensel and de Lange, 1997). RT-PCR
amplification of transcripts of all these genes except FOXD3
demonstrate their presence in both D3 and H1 cells (Fig.
2B). Expression of FOXD3 was detected only in mouse
cells. Immunostaining confirmed FGFR-4 protein expres-
sion on the cell surface of both human and mouse cells (Fig.
3A (a) and (b)). Expression of TERT, TERF1, and TERF2
genes in both mouse ES and human ES was consistent with
high telomerase activity measured with TRAP assay. Telo-
merase activity in both ES cell lines was as high as in HeLa
tumor cells (Fig. 3E).
We also tested the expression other cell surface markers
reported to be present on blastocysts or other stem cell
populations, such as gap junction proteins connexins-43
(Duval et al., 2002) and 45 (Rozental et al., 2000), glucose
transporter GLUT1 (Leppens-Luisier et al., 2001; Morita et
al., 1994; Pantaleon et al., 2001), and ABC transporter
BCRP-1/ABCG-1 (Cai et al., 2002; Lu et al., 2002; Zhou
et al., 2002, 2001). All of these genes could be readily
detected in both H1 and D3 cells (Fig. 3B). All except
GLUT-1 were absent in feeder cells (data not shown),
making these markers useful in distinguishing ES cells from
contaminating feeder populations. Connexin 43 expression
was confirmed by immunostaining in both mouse and
human cells (Fig. 3A(c) and (d)). The antibody against
BCRP1 recognized only the mouse epitope in our experi-
ments (Fig. 3A(e)). The results of the RT-PCR and immu-
nostaining for stem cell-specific markers are summarized in
Table 3A. Markers detected in both mouse and human ES
cells (black boxes) or unique to human ES cells (gray boxes)
are highlighted.
Markers of differentiated phenotypes
Human ES cells, like nonhuman primate ES cells (but
unlike mouse ES cells) are able to differentiate into tropho-
blast in culture (Odorico et al., 2001; Thomson et al.,
1998a). To assess the expression of trophoblast-related
genes in H1 and D3 cells, we used published RT-PCR
primers for early trophoectoderm markers to analyze their
expression. Genes tested included Bex1/Rex3 (Williams et
al., 2002), eomesodermin (Russ et al., 2000), and four other
transcription factors: Mash2/Hash2, HEB, Hand-2 and HIF-
1beta/ARNT, all described by Janatpour et al. (1999). As
shown in Fig. 3C, both mouse D3 and H1 cells expressed
BEX1/REX3. In addition, D3, but not H1 cells, expressed
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(Abbott and Probst, 1995; Jain et al., 1998). Among other
trophoectoderm markers tested, eomesodermin was persis-
tently expressed in all human ES cell samples and HEB
transcripts appeared in some but not all samples (data not
shown). Mash2 and its human homolog Hash2 were also
present in some RNA preparations from both cell types (Fig.
2C). The results summarized in Table 3B suggest troph-
oectoderm-specific markers are differentially expressed in
human and mouse cells. In accordance with the RT-PCR
results, EST frequency counts for trophoectoderm markers
suggested high expression of HEB in both, undifferentiated
cells and embryoid bodies [7:12], while BEX1 [0:1] and
HAND2 [0:1] were expressed only in embryoid bodies.
ARNT was not detected in human ES cells.
Besides identification of a set of positive ES cell-specific
markers, we also sought to develop a set of negative
markers to assess the state of differentiation of current ESFig. 4. Comparison of cell cycle-related gene expression in undifferentiated D3 m
hybridization result is shown. (B) General comparison of the array results. (C) Q
represents a mean of two separate experiments for each cell type. Only genes with
values is available upon request. (D) RT-PCR verification of cell cycle microarracell lines. Genes that have been previously reported as
markers of early differentiation into germ layers or into
tissue-specific precursors were chosen as sensitive indica-
tors of differentiation. Results are summarized in Table 3C.
Several markers that were thought to be characteristic of
differentiation were expressed by undifferentiated cultures
of human and in mouse ES cells. Thus, GATA4, a zinc
finger transcription factor, thought to be important for early
endoderm/heart differentiation was present in both mouse
and human ES cell lines, although cardiac actinin was not
expressed (Fig. 3D and Table 3C). EST frequency analysis
confirmed expression of GATA4 (and detected no actinin) in
undifferentiated cells and in embryoid bodies [3:3]. Mouse
D3 cells expressed GATA2, which was not detected in
undifferentiated human ES cells using RT-PCR and EST
counts [0:1]. Another marker of visceral endoderm, alpha-
fetoprotein (AFP) was present in H1 cells (Fig. 3D and
Table 3C), although not detected by EST scan. Immunos-ouse and H1 human ES cells using cDNA microarrays. (A) Representative
uantification of the gene expression with ScionImage software. Each bar
expression of > 2% GAPDH are presented. The full list of genes and OD
y results for several genes.
Table 4
Comparison of the results of the cell cycle array with EST counts
Cell cycle Higher in D3 Percentage array
controla (%)
Estimated
frequencyb
G1 Cyclin D3 0.9 1
CDK4 4.6 7
p15 8.23 ND
Cullin 3 3.4 1
Cullin 4B 2.4 4
S MCM2 2.4 23
MCM3 2.4 38
MCM7 3.7 19
Ki67 4 0
G2 Cyclin F 1.8 1
M P55 CDC20 2.4 7
PRC1 0.9 6
p53/DNA GADD45A 4.3 1
damage 14-3-3e ND ND
SUMO-1 3.4 5
UBE3A 3.1 2
RPA3 0.9 0
Cell cycle Equal in D3
and H1
Percentage array
controla (%)
Frequency
countsb
G1 Cyclin E1 8 0
CKS1 7.6 3
NEDD8 6.7 3
SKP1A 9.5 5
E2F4 12.2 3
S Cyclin A 8.9 3
Cyclin G1 46 4
PCNA 6.4 10
MCM4 15.6 34
MCM5 4.6 13
G2 Cyclin B1 14 8
Cyclin B2 5 6
M RBX1 5.5 0
P53 DNA p53 4.6 4
damage MDM2 7.3 0
Cell cycle Higher in H1 Percentage array
controla (%)
Frequency
countsb
G1 Cyclin D2 18 5
p16ink 61 ND
CKS2 6.4 3
S MCM6 82 12
G2 None
M None
p53 DNA cAbl 4.6 ND
damage UB-C 65.5 0
UB-E1 6.1 44
a %GAPDH expression (OD) on the array.
b Results of EST scan; maximum detected frequency count was 44.
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markers in both D3 and H1 cells. For instance, significant
number of human H1 cells expressed vimentin. Double
staining for vimentin and for a human marker of undiffer-
entiated state TRA-1-81 showed no co-localization, suggest-
ing that vimentin-positive cells were a differentiated cell
population (Fig. 3A(g)). Previous studies of human cell ES
lines H7 and H9 cultured on Matrigel (Carpenter et al.,
2001) demonstrated expression of neuronal precursor mark-
er beta-tubulin class III in these cultures and was confirmed
using EST frequency analysis for undifferentiated cells and
embryoid bodies [2:8]. When the presence of beta-tubulin
class III was tested with immunostaining in our cultures,
human H1 cells were mostly beta-tubulin class III-negative,
except at the edge of the colony, where expression of SSEA-
4 antigen has been lost (Fig. 3A(i) and (k)). However, beta-
tubulin class III was found in mouse D3 cell cultures, where
its expression co-localized with the mouse marker of undif-
ferentiated cells, SSEA-1 (Fig. 3A(h) and (j)). On the other
hand, no vimentin was found in mouse ES cells (Fig. 3A(f)).
Patterns of expression of beta-tubulin class III and vimentin
in D3 and H1 cells were confirmed with RT-PCR (Fig. 3D).
Mouse ES cells were grown without feeders for RNA
purification and did not express keratin 14 (Fig. 3D), neither
was it expressed in human cell ES lines H1, H7, and H9
cultured on Matrigel without feeders (see Fig. 8B).
In summary, broader analysis of stem cell markers
identified additional partially overlapping marker sets
markers, which could be used to assess the state of human
and mouse ES cell cultures.
Comparison of cell proliferation and cell death gene
expression in D3 and H1 ES cell lines
Given the differences observed by immunocytochemis-
try and by RT-PCR in marker and gene expression, it was
reasoned that human and mouse cells will display addi-
tional differences in their cell cycle regulation and cytokine
response. To directly test this, we employed focused
microarrays containing 96 genes related to cell cycle or
apoptosis as previously described (Luo et al., 2002). To
avoid a bias in hybridization, arrays containing human
genes were used to probe expression in human cells, and
homologous arrays of mouse genes (80 out of 96 genes
were homologous) were used to assess expression in mouse
cells. Relative OD of each spot on the array was quantified
with ScionImage and normalized to GAPDH. All numbers
below are percentages of GAPDH expression. The results
of the cell cycle microarray are summarized in Fig. 4. As
can be seen in Figs. 4A and B, almost half of all genes on
each array was expressed, providing evidence for cell
proliferation in both types of ES cell cultures. Eleven of
the mismatched genes were present at low or undetectable
levels. Three genes which were absent on the mouse array
and present on the human array were expressed at detect-
able levels: CDC28 protein kinase 2 (UniGene: Hs.83758;6.4%; EST counts [3:0]; MAD2 (UniGene; Hs.19400;
3.97%; EST counts [6:3]); and CDC28 protein kinase 2
(UniGene Hs.83758; 6.42%). Mouse cells expressed two
genes that were absent on the human array: E2F-related
transcription factor (UniGene Mm.925; 6.13%) and p53-
activated gene 14-3-3e or tyrosine 3-monooxygenase/tryp-
tophan 5-monooxygenase activation protein epsilon (UniG-
ene Mm.42972; 80.87%).
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cell cycle regulators are summarized and compared to EST
frequency scan for the same genes (see Table 4). Good
correlation between two methods was observed though a
few genes, which were not detected by EST scan (ND), were
expressed at low levels as assessed by array analysis. In
addition, the expression of two genes not present on the
array and elevated in mouse ES cells were confirmed as
being expressed E2F [2:2] and tyrosine 3-monooxygenase
[20:21].
As one would expect, markers of proliferation Ki67,
PCNA, and cyclins were expressed, although with different
patterns in each cell type. Expression of tumor suppressor
genes such as ATM, Rb and retinoblastoma-like proteins,
and of BRCA1 was not detected. Expression of p53 was low
in human cells, but was higher in mouse cells (4.2% vs.
7.5%, respectively). Negative regulators of the p53 and Rb
pathway such as mdm2 were present as well. Cell cycle
inhibitors p21, p27, p18, and p19 were undetectable by
hybridization, while p16 inhibitor was predominantly
expressed in H1 cells (60.9% vs. 3.73%). Moderate expres-
sion of p15 inhibitor (8.3%) was observed in mouse cells
only. Mouse cells also showed moderate expression (5.8%)Fig. 5. Comparison of apoptosis-related gene expression in undifferentiated D3
comparison of the array results. (B) RT-PCR confirmation of TNFR-2 and TRAF1
ScionImage software. Mode OD of each gene/spot was calculated and normali
experiments for each cell type. Only genes with expression of >2% GAPDH areof one of the DNA-binding replication proteins, RPA3
(Unigene: Mm.29073), which was absent in human cells.
The ubiquitination pathway appeared more active in H1
cells as ubiquitin C was virtually undetectable in mouse D3
cells but was present at high levels (65.5%) in human cells.
GADD45 was readily detectable in the mouse D3 line
(20.1%) but was low or absent in human cells (1.5%).
MCM genes 2 through 7, which are thought to be ‘‘DNA
licensing factors’’, which bind to the DNA after mitosis and
enable DNA replication before being removed during S
phase (Lei and Tye, 2001; Nishitani and Lygerou, 2002),
were differentially expressed as well. MCM-6 was abun-
dantly expressed in human H1 cells (81.7%; EST counts
[12:5]), while MCM-2, MCM-3, and MCM-7 expression
was more prominent in D3 cells (14.8%, 8.7% 12.7%,
respectively), although EST analysis detected quite high
levels of MCM-2 [23:8] and MCM-7 [19:3], but not
MCM-3 [1:0]. MCM-4 and MCM-5 were equally expressed
(around 13–15%; EST counts [34:9] and [13:3], respective-
ly). Expression of selected genes (ubiquitin C, p16ink,
cyclin D2, mdm2, and GADD45) was confirmed with RT-
PCR. Similar to the microarray results, ubiquitin C and
CDK4 inhibitor p16ink were expressed at higher levels inmouse and H1 human ES cells using cDNA microarrays. (A) General
expression in human cells. (C) Quantification of the gene expression with
zed to GAPDH expression. Each bar represents a mean of two separate
presented. The full list of genes and OD values is available upon request.
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levels (Fig. 4B).
Examining regulation of cell death pathways showed the
presence of a limited subset of genes (Fig. 5). Nine and 17
genes were expressed at detectable levels in D3 and H1
cells, respectively (see Fig. 5A for the lists of these genes).
Surprisingly, only 2 out of these 24 genes were expressed in
both cell types. One was the anti-apoptotic BCL2-related
gene MCL-1 (27.3% and 30.6% of for D3 and H1 cells,
respectively); and the other was BAX (6.2% and 7.9% for
D3 and H1, respectively), which causes cytochrome c
release from mitochondria. Mouse, but not human cells,
expressed additional BAX-related gene BIK (7.4% and 0%
for D3 and H1, respectively). Human cells in contrast,
expressed BAK (63.7%) and HRK (63.29%), other BAX-
related genes.
Many of the genes that were present at detectable levels
in undifferentiated mouse ES cell cultures were associated
with the p53 pathway (Fig. 4B). Indeed, the p53 effecter
GADD45 was highly expressed only in mouse ES cells
(29.5%), and expression of another p53-dependent gene 14-Fig. 6. Comparison of cytokine expression in undifferentiated mouse and human E
in human and mouse ES cells: yellow—high expression, no fill—low expression
gene expression with ScionImage software. Each bar represents a mean of two se
GAPDH are presented. (C) RT-PCR results for genes highly expressed in human3-3e (Mm.42972) was also high in D3 cells, although this
gene had no counterpart in human apoptosis array. Human
ES cells in contrast expressed higher levels of negative
regulators of p53 function. These included mdm2 ubiquitin
ligase, which binds p53 and destines it for ubiquitination
and degradation (8.5% and 16.4% for D3 and H1 cells,
respectively).
In contrast to mouse ES cells, human ES cells
expressed several genes associated with TNF receptor
signaling. This includes high levels of p75 TNFR-2
(84.5% and 0% for H1 and D3 cells, respectively) and
TNF receptor-docking molecule TNF receptor-associated
factor TRAF1 (60.0% and 0.3% for H1 and D3 cells,
respectively). These results have been confirmed with RT-
PCR (Fig. 5B), TRAF6, and TRAF4, as well as one of the
members of the receptor-interacting family of Ser/Thr
kinases RIP2 (5.3%) were also expressed predominantly
in human ES cells, although to the lesser extent (RIP2
homologue was absent on the mouse array). Human ES
cells demonstrated differentially high expression of a BLK
gene (Hs.2243 and Mm.3962; 79.3% and 0%, respective-S cells using cDNA microarrays. (A) The most prominently expressed genes
; blue—no counterpart gene present on the array. (B) Quantification of the
parate experiments for each cell type. Only genes with expression of >4%
cells.
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in NF-kappa-B activation during B cell development.
Many of the genes known to play an important role in
cell death such as caspase 4/5, 8/9, FAS and FAS ligand
were not expressed at detectable levels in either cell type.
Human ES cells expressed, however, caspase 14, which
was absent in mouse cells, while death receptor genes DR3
(UniGene: Hs.180338 and Mm.101198; 0% and 6.2%) and
DR6 (which was only present on a mouse array, UniGene
Mm.22649; 28.9%) were significantly expressed.
Overall these results show that both mouse and human
cells are actively dividing cells, with mouse cells less
protected from apoptosis consistent with the observation
that many apoptotic cells are found in mouse ES colonies
(see Fig. 1A). The pathways used to regulate cell cycle and
apoptosis differ significantly with a limited overlap of
genes.
Cytokine expression by ES cells
Given the difference between mouse and human marker
expression and the differences in expression of cell cycle
and cell death pathways genes, we felt that differences in
cytokines may also be apparent. While cytokines can vary
greatly and message levels tend to be low, the overall
pattern of expression can nevertheless provide a basis for
comparison. The cytokine microarray contained probes for
major cytokine subsets: bone morphogenetic proteins
(BMPs), colony-stimulating factors (CSFs), fibroblastFig. 7. Analysis of LIF receptor (LIFR) expression. (A–D) RT-PCR analysis. Ex
human H1 cells (C). The same mouse and human primers and PCR conditions we
and mouse E 9.5 embryo (B) and human NEP and human placenta (D). (E–H) im
antibody against LIFR (E and G, respectively) and with the antibody against gp1growth factors (FGFs), interferons (INFs), insulin-like
growth factors (IGFs), interleukines (ILs), platelet-derived
growth factors (PDGFs), transforming growth factors
(TGFs), tumor necrosis factors (TNFs), vascular endothelial
growth factors (VEGFs), many of which are known to be
active during development. As can be seen in Fig. 6, the
overall patterns of cytokine expression in human and mouse
ES cells were different (Fig. 6A). Expression of many of the
genes shown to be elevated by microarray analysis was
confirmed by EST scan (Brandenberger et al., submitted for
publication) or MPSS (our unpublished results) and a
smaller number were confirmed by RT-PCR (Fig. 6C).
Few genes, IL-15, (Hs.168132), IL-11 (Hs.1721); pleiotro-
phin (Hs.44), VEGF (Hs.73793), BMP2 (Hs.73853), and
TNFSF14 (LIGHT) (Hs.129708) were moderately
expressed in both types of cells (Fig. 6B). The repertoire
of cytokines expressed in mouse D3 cells was richer than in
human cells (Fig. 6B).
LIFR/gp130 signaling pathways
We and others have noted that LIF is not required to
maintain self-renewal of human ES cells, while it is critical
for the maintenance of mouse cells. To identify the basis
for the absence of the LIF requirement, we examined
expression of both subunits of the LIF receptor: specific
LIF receptor (LIFR) subunit and signal transducer gp130.
As can be seen in Fig. 7C, LIFR message was absent in
H1 cells, while LIFR could be readily detected in mousepression of LIFR and its signal transducer gp130 in mouse D3 (A) and in
re used with control RNA samples from mouse neuroepithelial (NEP) cells
munostaining results. Mouse D3 and human H1 cells were stained with the
30 (F and H, respectively). See Table 2 for antibody specifications.
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RNA preparations from H1, H7, and H9 cells had low
levels of LIFR mRNA (EST analysis of these cells
confirmed low expression of LIFR [1:1]), while the newly
developed human ES cell line I-6 expressed significant
levels of LIFR (see Fig. 8B). The failure to detect
expression of LIFR in H1 cells could not be attributed
to technical issues as it was verified with two different sets
of LIFR primers (data not shown). Both sets of primers
identified LIFR in human neuroepithelial cells and in
human placenta (Fig. 7D). Absence of LIFR message in
H1 cells was consistent with immunostaining results: no
LIF receptor was detected on the surface of H1 cells (Fig.
7G), although the same antibody detected LIFR on mouse
cells (Fig. 7E). Expression of gp130, a signal-transducing
subunit of LIFR, was high in mouse cells and was readily
detected by RT-PCR (Fig. 7A) and immunostaining (Fig.Fig. 8. Comparison of gene expression profiles in different human ES lines. (A) th
ES cells according to RT-PCR analysis (see Figs. 3B–D and Table 3). (B) expressio
ES cell lines and from the pooled RNA sample of H1, H7, and H9 cells grown
mytomycin C and incubated with ES cell medium for 5 days (‘‘feeders’’). (C) su
expression according to cDNA microarrays. (D) comparison of cell cycle gene e
cDNA microarray. Each bar is percentage of GAPDH.7F). However, gp130 expression varied among human ES
lines. H1 cells expressed low levels of gp130 gene (Fig.
7C), while no message for gp130 was found in H9 cells
and in cells grown without feeders on Matrigel (H1, H7
and H9 RNA pool) (see Fig. 8B). The latter result is in
accordance with zero EST counts for gp130 [0:6] in these
cells. Since feeder cells also expressed gp130, it might be
that the message for gp130 detected in RNA preparations
from H1 cells can be attributed to contamination with
feeder RNA. Indeed, immunofluorescence experiments
showed quite low gp130 protein on the surface of H1
cells (Fig. 7H). The variable expression of gp130 and
LIFR suggested that this pathway is not active at early
stages of huES cell self-renewal and is consistent with our
observations that several inhibitors of this pathway are
actively transcribed (Brandenberger et al., Geron personal
communication see also Table 5).e list of genes that are differentially expressed in human H1 and mouse D3
n of these genes was analyzed by RT-PCR in RNA samples from H1, H9, I6
without feeders (‘‘pooled’’) and from fibroblast feeder cells treated with
mmary of the differences between human H1 and mouse D3 cells in gene
xpression in H1, H9, BN02 and ‘‘pooled’’ RNA samples using cell cycle
Table 5
EST scan and MPSS were used to examine the expression of LIF pathway
genes as described in Brandenberger et al. (personal communication)
Locusid LIF pathway gene MPSS tmp EST scan
3589 Interleukin 11 nd 0
3976 ILIF nd 2
3569 IL-6 nd nd
5008 Oncostatin M nd nd
1489 Cardiotrophin 1 nd nd
1270 CNTF nd nd
3977 LIFR nd 1
5781 PTP, nonreceptor type 11 37 4
3572 gp130//IL-6RST nd 0
3570 IL-6R nd nd
1271 CNTFR nd 0
9180 Oncostatin M Receptor nd 2
3718 Janus kinase 3 nd 0
3716 Janus kinase 1 22 0
3717 Janus kinase 2 nd nd
9655 Suppressor of
cytokine signaling 5
8 1
9306 Suppressor of
cytokine signaling 4
nd 2
8651 Suppressor of
cytokine signaling 1
nd nd
122809 Suppressor of
cytokine signaling 7
nd 1
9021 Suppressor of
cytokine signaling 3
nd 0
51588 Protein inhibitor of
activated STAT
protein PIASy
107 5
8554 Protein inhibitor of
activated STAT, 1
24 1
10401 Protein inhibitor of
activated STAT3
54 5
6778 Signal transducer and
activator of transcription 6
12 1
6774 Signal transducer and
activator of transcription 3
nd 9
6772 Signal transducer and
activator of transcription 1
55 4
6773 Signal transducer and
activator of transcription 2
nd 0
6775 Signal transducer and
activator of transcription 4
nd nd
6776 Signal transducer and
activator of transcription 5A
37 2
55250 Signal transducer and
activator of transcription 3
interacting protein 1
34 2
Note the absence or low levels of expression of receptor and transducer
components and the relatively high levels of inhibitors of the pathway such
as phosphatase, PIAS and SOCS genes. nd = not detected, 0 = absent in ES
cells but present after differentiation, tpm = transcripts per million, MPSS =
massively parallel signature sequencing.
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conserved in independently isolated ES cell lines
The significant differences observed between mouse and
human ES cells in expression of pluripotency/differentiation
markers, LIFR/gp130, apoptosis and cell cycle-relatedgenes, and cytokines raised the possibility that differences
were due to intrinsic differences in human and mouse
cultures. Alternatively, these differences could arise from
small differences in how cell lines were derived and main-
tained. To directly address this, we obtained RNA from two
additional human ES cell lines: H9.2 clone of H9 and a
newly derived line I-6 (Amit and Itskovitz-Eldor, 2002) that
have been derived and propagated in a different lab. In
addition, we tested pooled RNA sample from three different
cell lines (H1, H9, and H7) that were propagated on Matrigel
without feeders for 50 passages. Fig. 8A presents a list of
markers that have been found differentially expressed in H1
and D3 cells (see Figs. 3B, C and D and Table 3). FOXD3,
ARNT, beta-tubulin class III and GATA2 were not expressed
in H1 cells and were present in D3 cells. As shown in Fig.
8B, all these genes were also absent in all human cell lines
tested, while eomesodermin, HEB, AFP, and POTE (genes
that were expressed in H1 but not in D3 cells) were present in
other human cell lines as well. Keratin-14 message was
absent in the pooled RNA from feeder-free human ES cells,
and was present in feeder cell RNA, which confirms its
origin from mouse fibroblasts.
Since microarray analysis provided the broadest over-
view of the cell’s gene expression (see summary in Fig.
8C), we sought to investigate whether gene expression
profile of H1 cells will be reproducible in other human ES
cell lines. We performed cell cycle microarray analysis
with H9 cells, with the human ES line BG02 from
Bresagen and with pooled human ES cell RNA and with
two additional lines (Fig. 8 and data not shown). A
remarkable similarity in the pattern of expression of cell
cycle genes among different populations of human ES cells
was observed and this pattern was clearly distinct from that
seen in mouse ES cells (Fig. 8D). Thus, it appears likely
that the differences we observe between mouse and human
ES cells reflect underlying fundamental differences in cell
biology of the two populations.Discussion
We have compared the expression of almost 400 genes in
human and mouse ES cells that have been maintained in an
undifferentiated state on MEF’s under standard protocols.
Our results show that mouse and human cells share similar-
ities in expressing markers of the pluripotent state. The
expression of these markers together with the absence of
markers of differentiation constitutes a signature profile of
undifferentiated ES cell cultures (Figs. 1–3, Table 3) and is
similar to recent results reported by microarray comparison
(Sato et al., 2003). The immunostaining markers and validat-
ed primers reported in this study will form the basis for
developing a well-tested set of markers, which will allow
careful, regular monitoring of ES cells in culture. It is
important to note that the primers used in this study have
been verified to amplify specific cDNA fragments in control
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protocols. Band sizes were selected such that multiplex RT-
PCR could be readily performed or amplified DNA fragments
could be used to develop focused ES cell microarrays.
However, signature profiles described in mouse and human
ES cells were not identical. Apart from previously reported
differences in expression of embryonic antigens (Henderson
et al., 2002) and the ability to differentiate into trophoecto-
derm (Odorico et al., 2001; Thomson et al., 1998a), other
differences between human and mouse ES cells have been
identified in these studies. These differences were conserved
in all human ES lines tested (Fig. 8 and Table 6).
An important difference that we have noted is LIF
receptor expression. LIFR message was low or absent in
H1 and variable in all human ES lines tested, while LIFR
could be readily detected in mouse ES cell cultures. Our
failure to detect LIFR and gp130 was confirmed by an
EST scan where we likewise detected inconstant/low levels
of LIF receptor (Brandenberger et al., submitted for
publication; Carpenter et al., 2004; Rosler et al., 2004).
These results are consistent with the lack of a LIF
requirement for maintenance of undifferentiated human
ES cell lines and with the altered LIF signaling observed
in human teratocarcinoma lines (Schuringa et al., 2002)
and the high levels of suppressors of the cytokine signaling
pathway (Brandenberger et al., submitted for publication).
Interestingly, EST enumeration detected significant levels
of LIF embryoid bodies [2:9] suggesting that LIF may play
a role in differentiation of these cells. Elucidation of the
role of LIF in paracrine regulation of ES cells requires
further investigation.
The presence of a LIF-independent self-renewal pathway
has been described in mice (Dani et al., 1998) though it is
thought to play a minor role in self-renewal (reviewed in
Burdon et al., 2002; Niwa, 2001). It is possible, however,
that this pathway plays a larger role in human ES cell
cultures. More recently, a homeobox protein, nanog, wasTable 6
Distinguishing features of mouse and human ES cells
Marker Mouse Human
Morphology More diverse Rounded with sharp
boundaries
SSEA-1 Present Absent
SSEA-4 Absent Present
Vimentin Absent Present
Trophoectoderm
markers
Absent Present
h-III tubulin Present h-5 tubulin present
LIFR High Low/variable
Gp130 High Low/variable
FGF4 High Absent
HRASP Required Pseudogene
E-hox Required No orthologue present
Fox-D3 Present/required Low/absent
Major differences between mouse and human ES cells (see also Fig. 8)
based on present results and unpublished results (Brandenberger et al.,
personal communication) are summarized.shown to be involved in self-renewal via activation of a LIF
independent pathway (Chambers et al., 2003; Mitsui et al.,
2003). Nanog expression is conserved in all human lines
examined so far (Brandenberger et al., submitted for
publication).
Another surprising difference between human and
mouse ES cells, which we have noted, is absence of
FoxD3 expression. The results of EST scan for FoxD3
[0:0] were consistent with our RT-PCR results although it
should be noted that some reports (reviewed in Carpenter
et al., 2003) have suggested expression of FoxD3 in
human ES cells. In contrast to human cells, FoxD3 was
readily detected in mouse ES cell cultures. FoxD3 or
GENESIS is expressed early in mouse embryonic devel-
opment, and abrogation of FoxD3 function leads to a
failure of the blastocyst to develop beyond the four-cell
stage (Hanna et al., 2002). In addition, FoxD3 is critical
for endodermal differentiation when it antagonizes the
activity of OCT3/4 (Guo et al., 2002). Differences in
FoxD3 expression between mouse and human ES cells,
if verified, would further illustrate fundamental differences
in the biology of these cells.
Our studies of patterns of expression of cell cycle,
apoptosis, and cytokine genes uncovered additional funda-
mental species-specific differences. While it is impossible to
discuss all findings, it is worth highlighting a few critical
differences that are not only of quantitative nature, but
suggest that different signaling pathways are operative and
thus may provide some insights on ES cell biology. For
instance, components of a p53 pathway that controls growth
arrest and cell death in response to DNA damage (Gottifredi
et al., 2000; Schultz et al., 2000) were much more active in
mouse ES cells, while human ES cells expressed TNF
receptor 2, which has been implicated in a survival signaling
cascade (Peschon et al., 1998) probably through NF-kB
activation (Dopp et al., 2002). Even when similar pathways
were utilized, different members of the same family were
more or less abundant. MCM6, for example, was high in
human cells and MCM-2, MCM-3, and MCM-7 were high
in mouse cells. Overall, the differences observed in array
analysis between human and mouse ES cells were unex-
pectedly large, which suggests that caution needs to be
exercised in extrapolating from studies in mouse cells.
Our analysis identified other unexpected findings. Hu-
man ES cells expressed additional markers of trophoecto-
derm, eomesodermin (Russ et al., 2000), and HEB
(Janatpour et al., 1999), which was consistent with obser-
vations that human ES cell lines could differentiate into
trophoectoderm (Odorico et al., 2001; Thomson et al.,
1998a). An additional surprising observation was the pres-
ence of a contaminating population of vimentin-immunore-
active cells interspersed within undifferentiated ES cells.
Message for vimentin was present in RNA preparations as
well. Vimentin-positive cells appear intercalated among the
other cells in the colonies and cannot be readily distin-
guished by morphology. However, double immunostaining
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no co-localization, suggesting that these cells are differen-
tiated cells. Mouse cells did not express vimentin but
expressed beta-tubulin class III, which co-localized with
SSEA-1. Recently, ES cells were found to express beta-
tubulin class V (unpublished results), which might cross-
react with our reagents.
Two alternative possibilities could explain numerous
differences observed between mouse and human ES cells.
One possibility is that culture conditions for growing
human ES cells were not optimized for maintaining the
cells in an undifferentiated state, and that the differences
that we observed will be resolved as culture conditions
improve. The observed differences may reflect some de-
gree of differentiation, atypical expression of certain
markers or transdifferentiation. We note, for example, the
small number of differentiated cells of unknown character
that were present in human ES cell cultures, and the
expression of several markers of differentiated cells such
as vimentin, keratin14, and beta III tubulin. However, our
initial examination of additional human ES cell lines
suggests that culture conditions alone could not explain
the observed differences between mouse and human ES
cells. Besides the H1 line, we have studied H9 cells and
the newly developed line I-6, as well as ES cells grown
without feeders for 50 passages and cell lines from
Bresagan. The gene expression patterns in all these lines
appeared similar to each other and differed from mouse ES
cells. Since these lines were grown in different laboratories
under distinct culture conditions, we would argue that
observed dramatic differences between human and mouse
cells reflect underlying differences in the biology of the
cells rather than differences secondary to a response to the
culture environment. However, we suggest that a careful
assessment of a larger number of lines with additional
markers will be required to make a final determination.
An alternate, equally plausible, explanation for the differ-
ences between mouse and human cells is that human ES
cells may have been isolated at a slightly different perhaps
earlier stage of blastocyst cell maturation, and thus the
observed differences reflect the stage of harvesting of
ICM. This possibility is consistent with the reported ability
of human ES cells (and the inability of mouse ES cells) to
differentiate into trophoblast or to contribute to placental
development in vivo, and with our current observations of
the expression of several early trophoectoderm markers and
the expression of some of the putative differentiation
markers such as AFP and GATA4 that would be consistent
with the possibility that early harvested ES cells may retain
the capability to make extra-embryonic endoderm and
mesoderm.
In summary, our results show that the overall strategies
to regulate self-renewal and differentiation are likely similar
among ES cell lines from different species. However,
significant differences are present and it will be important
to identify and characterize such differences before a usefulset of markers for the differentiated and undifferentiated
state can be developed. Once such a marker set is devel-
oped and validated, it is likely that it can be used across all
the 60 or so lines that have been identified. Our future
experiments will be directed at extending the analysis to
other lines as they become available and understanding the
functional significance of the molecular differences we
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